These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 797239)

  • 1. [Therapeutic action of neuroleptics and their effects in the psychology of schizophrenia].
    López-Ibor Aliño JJ
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1976; 4(3):171-80. PubMed ID: 797239
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical study on five depot neuroleptics. Comparison of effective profiles of fluphenazinedecanoate, fluspirilene, penfluridol, perphenazine-enanthate and pipothiazinepalmitate].
    Angst J; Woggon B
    Arzneimittelforschung; 1975 Feb; 25(2):267-70. PubMed ID: 1091272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxyprothepine in schizophrenia.
    Taussigová D; Vinar O; Bastecký J
    Act Nerv Super (Praha); 1974 Aug; 16(3):163-5. PubMed ID: 4609063
    [No Abstract]   [Full Text] [Related]  

  • 4. A controlled comparison of oxypertine and perphenazine in schizophrenic psychoses.
    Svestka J; Náhunek K; Rodová A; Cesková E
    Act Nerv Super (Praha); 1974 Aug; 16(3):165-6. PubMed ID: 4608706
    [No Abstract]   [Full Text] [Related]  

  • 5. [Unexpected therapeutic effects of tybamate in psychoses].
    Turns D; Denber HC; Turns CN
    Ann Med Psychol (Paris); 1968 Jul; 2(2):216-20. PubMed ID: 5684178
    [No Abstract]   [Full Text] [Related]  

  • 6. The prediction of placebo effect in functional psychoses.
    Vinarová E; Vinar O
    Act Nerv Super (Praha); 1973 Mar; 15(1):53-4. PubMed ID: 4572683
    [No Abstract]   [Full Text] [Related]  

  • 7. [The clinical picture of action of floropipamide. Results of several years of clinical studies].
    Bente D; Flegel H; Katscher H; Pfeiffer W
    Arzneimittelforschung; 1966 Feb; 16(2):312-4. PubMed ID: 4861660
    [No Abstract]   [Full Text] [Related]  

  • 8. [Possibilities and limits of depot neuroleptic therapy of schizophrenic psychoses].
    Glatzel J
    Ther Ggw; 1970 Jun; 109(6):834-6 passim. PubMed ID: 5453883
    [No Abstract]   [Full Text] [Related]  

  • 9. [Psychopharmacological experiences with methophenazine with particular reference to Leonhard's classification of endogenous psychoses].
    Neumann J; Schulze HA
    Psychiatr Neurol Med Psychol (Leipz); 1966 Jan; 18(1):11-7. PubMed ID: 4862323
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparative trial of oxypertine and chlorpromazine in the treatment of acute psychoses.
    Wadzisz FJ
    Curr Ther Res Clin Exp; 1969 Dec; 11(12):784-92. PubMed ID: 4984044
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacopsychiatric experiences with methophenazine].
    Petrilowitsch N
    Med Welt; 1966 Nov; 48():2634-7. PubMed ID: 5979465
    [No Abstract]   [Full Text] [Related]  

  • 12. [Considerations on the therapeutic management of mixed psychoses and of depressive manifestations symptomatic of schizophrenia].
    Scala A
    Osp Psichiatr; 1967; 35(4):501-34. PubMed ID: 5607254
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clotepin].
    Melich H
    Cas Lek Cesk; 1971 Apr; 110(17):404-5. PubMed ID: 5576292
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mechanisms of structural modifications of syndromes in the course of treatment of schizophrenia].
    Khvilivitskiĭ TIa
    Vestn Akad Med Nauk SSSR; 1971; 26(5):86-90. PubMed ID: 5172989
    [No Abstract]   [Full Text] [Related]  

  • 15. [Late dyskinesia caused by neuroleptics. Survey on 1,660 psychiatric hospital patients].
    Bourgeois M; Graux C; Arrethche-Berthelot N
    Ann Med Psychol (Paris); 1976 May; 1(5):737-46. PubMed ID: 970829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium in schizo-affective disorders.
    Dinsmore PR; Ryback R
    Dis Nerv Syst; 1972 Dec; 33(12):771-6. PubMed ID: 4668969
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical studies with a neuroleptically active dibenzothiazepine derivative].
    Bente D; Engelmeier MP; Heinrich K; Hippius H; Schmitt W
    Arzneimittelforschung; 1966 Feb; 16(2):314-6. PubMed ID: 4861661
    [No Abstract]   [Full Text] [Related]  

  • 18. Predictors of therapeutic responsivity to thiothixene in schizophrenics.
    Sterlin C; Oliveros R; Ban TA
    Int Z Klin Pharmakol Ther Toxikol; 1968 Jul; 1(5):394-6. PubMed ID: 4882603
    [No Abstract]   [Full Text] [Related]  

  • 19. [What should the general practitioner know about the treatment of chronic schizophrenia with long-acting neuroleptics?].
    Beier R; Friemert K; Vehreschild T
    Z Arztl Fortbild (Jena); 1973 Dec; 67(23):1206-7. PubMed ID: 4791840
    [No Abstract]   [Full Text] [Related]  

  • 20. Pimozide compared with fluphenazine in schizophrenia.
    Kenway AK; Masheter HC
    Br J Clin Pract; 1971 Feb; 25(2):69-72. PubMed ID: 4927983
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.